The Liver Meeting 2019-Getting the NASH/Obese Patient to Transplant

Video Transcription

Video Summary

Dr. Gomez discussed the challenges of managing patients with NASH and obesity, particularly in the context of liver transplant. He highlighted the global rise in obesity and the impact it has on chronic liver diseases like NASH and cirrhosis. Obesity is a major risk factor for cardiovascular disease, diabetes, and liver conditions. The progression of fibrosis in NASH is closely linked to obesity. Dr. Gomez emphasized the importance of weight loss before liver transplant to improve outcomes and increase access to available grafts. Lifestyle interventions, such as diet and exercise, are key in managing obesity and NASH. Surgical options like bariatric surgery, specifically sleeve gastrectomy, were discussed as potential interventions to promote weight loss prior to transplant. The use of endoscopic bariatric therapies, like intragastric balloon therapy, was also mentioned as a minimally invasive option for selected patients. Long-term success in weight loss and maintaining a healthy weight post-transplant were also key considerations in managing these complex patients.

Asset Caption

Presenter: Victoria Gomez

Keywords

NASH management

obesity challenges

liver transplant

fibrosis progression

weight loss interventions

bariatric surgery

endoscopic bariatric therapies